Tin tức & Cập nhật

Albuminuria reduction accounts for treatment effect on CKD outcomes in T2D
Albuminuria reduction accounts for treatment effect on CKD outcomes in T2D
17 Dec 2023

Early albuminuria reduction with finerenone in patients with chronic kidney disease (CKD) and type 2 diabetes (T2D) is responsible for a huge proportion of the treatment effect against CKD progression and facilitates a modest amount of the effect against cardiovascular outcomes, reports a study.

Albuminuria reduction accounts for treatment effect on CKD outcomes in T2D
17 Dec 2023
Obesity persists in axSpA, especially in socially deprived patients
Obesity persists in axSpA, especially in socially deprived patients
11 Dec 2023

Obesity appears to be prevalent among patients with axial spondyloarthritis (axSpA) compared to the general population, according to a Swiss study, noting that socially disadvantaged individuals are most affected by this comorbidity.

Obesity persists in axSpA, especially in socially deprived patients
11 Dec 2023
Alanine tied to diabetes, BP, lipid profile but not CAD
Alanine tied to diabetes, BP, lipid profile but not CAD
07 Dec 2023

Plasma alanine or factors affecting alanine appear to contribute to an increased risk of diabetes, higher blood glucose, low-density lipoprotein cholesterol (LDL-C), and blood pressure (BP), but not coronary artery disease (CAD), reports a study.

Alanine tied to diabetes, BP, lipid profile but not CAD
07 Dec 2023